Please login to the form below

Not currently logged in
Email:
Password:

BMS’ Brian Daniels to retire

He will step down from role as senior VP, global development and medical affairs
BMS Brian Daniels

Dr Brian Daniels is to retire from his role as senior VP, global development and medical affairs at Bristol-Myers Squibb (BMS) on July 1, 2014.

Dr Daniels has been with BMS since 2000 as VP of the immunology, pulmonary, and dermatology therapeutic area where he worked on such compounds as rheumatoid arthritis drug Orencia (abatacept). He took on his current role in 2008.

Francis Cuss, executive vice president and chief scientific officer, BMS said: "He has been a champion of the patients we serve, and I want to sincerely thank him for his loyalty and dedication to Bristol-Myers Squibb."

Prior to joining BMS, Dr Daniels spent four years at Merck Research Laboratories in clinical research where he ultimately assumed the role of senior director, pulmonary and immunology. He has also worked in clinical research at Genentech.

7th May 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics